文献速递乳腺乳腺X线

非钙化型导管原位癌:升级为浸润性癌的比率及预测因素

Noncalcified Ductal Carcinoma In Situ (DCIS): Rate and Predictors of Upgrade to Invasive Carcinoma.
PubMed 文献 · Acad Radiol · 2020-03-26

该回顾性研究纳入2007年1月至2016年12月连续诊断的非钙化型导管原位癌女性78例,评估手术升级为浸润性癌的比率及相关因素。结果显示升级率为21.8%(17/78),升级风险与患者年龄较大(68.1岁 vs 60.3岁,OR 1.08,p<0.01)及一级亲属乳腺癌家族史(41.2% vs 16.4%,OR 3.57,p=0.03)相关。

要点

  • 非钙化型DCIS手术升级为浸润性癌的比率为21.8%(17/78)。
  • 年龄较大与升级风险相关(68.1岁 vs 60.3岁,OR 1.08,p<0.01)。
  • 一级亲属乳腺癌家族史与升级风险相关(41.2% vs 16.4%,OR 3.57,p=0.03)。

关键影像表现/征象

  • 非钙化型DCIS最常见的乳腺X线表现为肿块(51.3%,40/78)和不对称致密(30.8%,24/78)。
  • 67.9%(53/78)的病例经筛查乳腺X线摄影检出,15.4%(12/78)因可触及异常区域就诊后诊断。

诊断标准与关键数值

  • 手术升级为浸润性导管癌的比率为21.8%(17/78)。
  • 升级组与未升级组年龄分别为68.1岁与60.3岁(OR 1.08,p<0.01)。
  • 升级组与未升级组一级亲属乳腺癌家族史比例分别为41.2%(7/17)与16.4%(10/61)(OR 3.57,p=0.03)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To determine the upgrade rate of noncalcified ductal carcinoma in situ (DCIS) and features that are associated with risk of upgrade to invasive disease at surgery.

MATERIALS AND METHODS: A retrospective review was conducted of consecutive women who were diagnosed with noncalcified DCIS from January 2007 to December 2016. Patient demographics, imaging findings, biopsy pathology results, and surgical outcomes were reviewed. The unpaired t test, chi-square test, and Fisher's exact test were used to compare features between the cases of DCIS that did and did not upgrade to invasive carcinoma at surgery.

RESULTS: Over a 10-year period, 78 women (mean age 62 years, range 30-88 years) were diagnosed with noncalcified DCIS. Two-thirds (67.9%, 53/78) of cases were detected on screening mammography, and 15.4% (12/78) of diagnoses were made after presentation with an area of palpable concern. The most common mammographic presentations of noncalcified DCIS were mass (51.3%, 40/78) and asymmetry (30.8%, 24/78). Seventeen cases (21.8%, 17/78) were upgraded to invasive ductal carcinoma (IDC) at surgery. Features associated with upgrade risk included older patient age (68.1 versus 60.3 years, OR 1.08, p < 0.01) and family history of breast cancer in a first-degree relative (41.2% [7/17] versus 16.4% [10/61], OR 3.57, p = 0.03).

CONCLUSION: In our study cohort, the upgrade rate of noncalcified DCIS to IDC at surgery is 21.8%. Upgrade risk is associated with older patient age and family history of breast cancer in a first-degree relative.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Lamb LR, Kim G, Oseni TO, et al. Noncalcified Ductal Carcinoma In Situ (DCIS): Rate and Predictors of Upgrade to Invasive Carcinoma. Acad Radiol. 2020. PMID: 32222328. doi:10.1016/j.acra.2020.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。